High temperature reversed-phase HPLC using deuterium oxide as a mobile phase for the separation of model pharmaceuticals with multiple on-line spectroscopic analysis (UV, IR, 1H-NMR and MS)
Abstract
The
* Corresponding authors
a LGC, The Heath, Runcorn, Cheshire, UK
b
AstraZeneca Pharmaceuticals, Mereside, Alderley Park, Macclesfield, Cheshire, UK
E-mail:
Ian.Wilson@astrazeneca.com
The
High temperature
D. Louden, A. Handley, S. Taylor, I. Sinclair, E. Lenz and Ian. D. Wilson, Analyst, 2001, 126, 1625 DOI: 10.1039/B107648P
To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.
If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.
If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.
Read more about how to correctly acknowledge RSC content.
Fetching data from CrossRef.
This may take some time to load.
Loading related content